-
61
Screen exposure, sleep quality, and language development in 6-month-old infants
Published 2025-02-01Get full text
Article -
62
-
63
-
64
Endometrial polyps with bizarre stromal cells: a Benign or a low-grade lesion?
Published 2025-02-01Get full text
Article -
65
-
66
-
67
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Published 2024-02-01Get full text
Article -
68
A Bibliometric Analysis of Medullary Thyroid Carcinoma From 2000 to 2022
Published 2024-07-01“…The United States (1436 articles), MD Anderson Cancer Center at the University of Texas (139 articles), and Dralle H (Department of General Surgery at Halle Wittenberg University Hospital, 61 articles) were the countries, research institutions, and authors with the highest number of publications, respectively. …”
Get full text
Article -
69
-
70
-
71
-
72
TAp63γ is the primary isoform of TP63 for tumor suppression but not development
Published 2025-02-01Get full text
Article -
73
Plant-nanoparticles enhance anti-PD-L1 efficacy by shaping human commensal microbiota metabolites
Published 2025-02-01Get full text
Article -
74
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email [email protected]: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
75
-
76
-
77
-
78
-
79
-
80